Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Glycoside Hydrolase Inhibitors
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Glycoside Hydrolase Inhibitors
Tree Number(s)
D27.505.519.389.320
D27.505.696.422.249
Unique ID
D065089
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D065089
Scope Note
Compounds that inhibit or block the activity of
GLYCOSIDE HYDROLASES
such as
ALPHA-AMYLASES
and
ALPHA-GLUCOSIDASES
.
Entry Term(s)
Intestinal alpha-Amylase Inhibitors
Pancreatic alpha-Amylase Inhibitors
alpha-Amylase Inhibitors, Pancreatic
alpha-Glucosidase Inhibitor
alpha-Glucosidase Inhibitors
Previous Indexing
alpha-Glucosidases/Antagonists and Inhibitors (1978-2014)
Public MeSH Note
2015
History Note
2015
Date Established
2015/01/01
Date of Entry
2014/06/26
Revision Date
2020/05/27
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
analysis (AN)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Enzyme Inhibitors [D27.505.519.389]
5-Lipoxygenase-Activating Protein Inhibitors [D27.505.519.389.086]
Acetaldehyde Dehydrogenase Inhibitors [D27.505.519.389.089]
Adenosine Deaminase Inhibitors [D27.505.519.389.092]
Adenylyl Cyclase Inhibitors [D27.505.519.389.108]
Aromatic Amino Acid Decarboxylase Inhibitors [D27.505.519.389.124]
Calcineurin Inhibitors [D27.505.519.389.174]
Carbonic Anhydrase Inhibitors [D27.505.519.389.200]
Catechol O-Methyltransferase Inhibitors [D27.505.519.389.237]
Cholinesterase Inhibitors [D27.505.519.389.275]
Cyclooxygenase Inhibitors [D27.505.519.389.310]
Gamma Secretase Inhibitors and Modulators [D27.505.519.389.315]
Glycoside Hydrolase Inhibitors [D27.505.519.389.320]
Cytochrome P-450 Enzyme Inhibitors [D27.505.519.389.335]
Folic Acid Antagonists [D27.505.519.389.350]
Histone Deacetylase Inhibitors [D27.505.519.389.360]
Hydroxymethylglutaryl-CoA Reductase Inhibitors [D27.505.519.389.370]
Integrase Inhibitors [D27.505.519.389.375]
beta-Lactamase Inhibitors [D27.505.519.389.400]
Lipoxygenase Inhibitors [D27.505.519.389.480]
Monoamine Oxidase Inhibitors [D27.505.519.389.616]
Nucleic Acid Synthesis Inhibitors [D27.505.519.389.675]
Ornithine Decarboxylase Inhibitors [D27.505.519.389.705]
Phosphodiesterase Inhibitors [D27.505.519.389.735]
Phosphoinositide-3 Kinase Inhibitors [D27.505.519.389.736]
Phospholipase A2 Inhibitors [D27.505.519.389.737]
Poly(ADP-ribose) Polymerase Inhibitors [D27.505.519.389.739]
Prolyl-Hydroxylase Inhibitors [D27.505.519.389.740]
Protease Inhibitors [D27.505.519.389.745]
Protein Kinase Inhibitors [D27.505.519.389.755]
Protein Synthesis Inhibitors [D27.505.519.389.760]
Proton Pump Inhibitors [D27.505.519.389.848]
Steroid Synthesis Inhibitors [D27.505.519.389.870]
Topoisomerase Inhibitors [D27.505.519.389.892]
Uncoupling Agents [D27.505.519.389.936]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hypoglycemic Agents [D27.505.696.422]
Glucagon-Like Peptide-1 Receptor Agonists [D27.505.696.422.125]
Glycoside Hydrolase Inhibitors [D27.505.696.422.249]
Amylin Receptor Agonists [D27.505.696.422.374]
Dipeptidyl-Peptidase IV Inhibitors [D27.505.696.422.500]
Insulin Secretagogues [D27.505.696.422.625]
PPAR-gamma Agonists [D27.505.696.422.688]
Sodium-Glucose Transporter 2 Inhibitors [D27.505.696.422.750]
Expand All
Collapse All
Glycoside Hydrolase Inhibitors
Preferred
Concept UI
M000594800
Scope Note
Compounds that inhibit or block the activity of
GLYCOSIDE HYDROLASES
such as
ALPHA-AMYLASES
and
ALPHA-GLUCOSIDASES
.
Terms
Glycoside Hydrolase Inhibitors
Preferred Term
Term UI
T000860495
Date
06/10/2014
LexicalTag
NON
ThesaurusID
NLM (2015)
alpha-Glucosidase Inhibitors
Narrower
Concept UI
M0587229
Scope Note
Compounds that inhibit
ALPHA-GLUCOSIDASE
.
Terms
alpha-Glucosidase Inhibitors
Preferred Term
Term UI
T848369
Date
08/27/2013
LexicalTag
NON
ThesaurusID
NLM (2015)
alpha-Glucosidase Inhibitor
Term UI
T001004244
Date
12/27/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
Pancreatic alpha-Amylase Inhibitors
Narrower
Concept UI
M0587231
Terms
Pancreatic alpha-Amylase Inhibitors
Preferred Term
Term UI
T000860493
Date
06/10/2014
LexicalTag
NON
ThesaurusID
NLM (2015)
alpha-Amylase Inhibitors, Pancreatic
Term UI
T000860494
Date
06/10/2014
LexicalTag
NON
ThesaurusID
NLM (2015)
Intestinal alpha-Amylase Inhibitors
Narrower
Concept UI
M0587236
Terms
Intestinal alpha-Amylase Inhibitors
Preferred Term
Term UI
T848382
Date
08/27/2013
LexicalTag
NON
ThesaurusID
NLM (2015)
page delivered in 0.156s